Provided by Tiger Trade Technology Pte. Ltd.

Argenx SE

984.04
-18.2700-1.82%
Post-market: 980.00-4.0400-0.41%18:38 EDT
Volume:226.46K
Turnover:224.42M
Market Cap:61.54B
PE:37.54
High:1,000.24
Open:991.05
Low:981.74
Close:1,002.31
52wk High:1,072.75
52wk Low:661.85
Shares:62.54M
Float Shares:62.45M
Volume Ratio:1.05
T/O Rate:0.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):26.21
EPS(LYR):19.57
ROE:23.63%
ROA:11.63%
PB:7.31
PE(LYR):50.28

Loading ...

Analysts Conflicted on These Healthcare Names: Senti Biosciences (SNTI), ALX Oncology Holdings (ALXO) and Argenx Se (ARGX)

TIPRANKS
·
May 18

argenx Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
May 16

Argenx price target raised to $1,059 from $1,007 at Evercore ISI

TIPRANKS
·
May 15

Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Siemens Healthineers AG (OtherSEMHF) and BioNTech SE (BNTX)

TIPRANKS
·
May 12

Stock Track | Argenx SE Soars 5.07% Intraday on FDA Approval for Vyvgart Label Expansion

Stock Track
·
May 11

Argenx price target raised to $1,016 from $1,013 at BofA

TIPRANKS
·
May 11

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 11

Argenx Wins FDA Approval Expanding Vyvgart Use to All Serotypes of Generalized Myasthenia Gravis

MT Newswires Live
·
May 11

FDA Approves Label Expansion For Argenx Treatment of Autoimmune Disease

Dow Jones
·
May 09

Argenx Se (ARGX) Receives a Buy from Jefferies

TIPRANKS
·
May 09

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 09

Argenx price target lowered to $1,170 from $1,230 at Morgan Stanley

TIPRANKS
·
May 08

Argenx price target raised to $1,135 from $1,120 at Guggenheim

TIPRANKS
·
May 08

argenx Is Maintained at Buy by Guggenheim

Dow Jones
·
May 08

RBC Capital Sticks to Their Buy Rating for Argenx Se (ARGX)

TIPRANKS
·
May 08

H.C. Wainwright Sticks to Their Buy Rating for Argenx Se (ARGX)

TIPRANKS
·
May 08

Analysts Offer Insights on Healthcare Companies: Alcon (ALC), Argenx Se (ARGX) and Definium Therapeutics (DFTX)

TIPRANKS
·
May 08

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Whitehawk Therapeutics (WHWK), Prime Medicine, Inc. (PRME) and Argenx Se (ARGX)

TIPRANKS
·
May 08

Argenx Posts 63% Q1 Sales Surge as New CEO Steers Expansion of Autoimmune Portfolio

TIPRANKS
·
May 07

Analysts Offer Insights on Healthcare Companies: Guardian Pharmacy Services, Inc. Class A (GRDN), biote (BTMD) and Argenx Se (ARGX)

TIPRANKS
·
May 07